Cargando…
Pulmonary-arterial-hypertension (PAH)-on-a-chip: fabrication, validation and application
Currently used animal and cellular models for pulmonary arterial hypertension (PAH) only partially recapitulate its pathophysiology in humans and are thus inadequate in reproducing the hallmarks of the disease, inconsistent in portraying the sex-disparity, and unyielding to combinatorial study desig...
Autores principales: | Al-Hilal, Taslim A., Keshavarz, Ali, Kadry, Hossam, Lahooti, Behnaz, Al-Obaida, Ahmed, Ding, Zhenya, Li, Wei, Kamm, Roger, McMurtry, Ivan F., Lahm, Tim, Nozik-Grayck, Eva, Stenmark, Kurt R., Ahsan, Fakhrul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592346/ https://www.ncbi.nlm.nih.gov/pubmed/32749432 http://dx.doi.org/10.1039/d0lc00605j |
Ejemplares similares
-
A Protocol for Fabrication and on-Chip Cell Culture to Recreate PAH-Afflicted Pulmonary Artery on a Microfluidic Device
por: Sarkar, Tanoy, et al.
Publicado: (2022) -
Peptide-Coated Liposomal Fasudil Enhances Site Specific
Vasodilation in Pulmonary Arterial Hypertension
por: Nahar, Kamrun, et al.
Publicado: (2014) -
Xanthine Oxidase-Derived ROS Upregulate Egr-1 via ERK1/2 in PA Smooth Muscle Cells; Model to Test Impact of Extracellular ROS in Chronic Hypoxia
por: Hartney, Tanya, et al.
Publicado: (2011) -
Heart of the Matter: Divergent Roles of Hypoxia-Inducible Factors in
Hypoxia-induced Right Ventricle Hypertrophy
por: Nozik-Grayck, Eva, et al.
Publicado: (2020) -
Cancer-on-a-Chip: Models for Studying Metastasis
por: Zhang, Xiaojun, et al.
Publicado: (2022)